Related Experiment Videos
Validation of a common data model for active safety surveillance research
J Marc Overhage1, Patrick B Ryan, Christian G Reich
1Regenstrief Institute, Indiana University, School of Medicine, Indianapolis, Indiana, USA. moverhage@regenstrief.org
Journal of the American Medical Informatics Association : JAMIA
|November 1, 2011
Summary
The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) effectively represents diverse healthcare database data for active safety surveillance. Analytic methods performed well, supporting large-scale systematic analysis.
Area of Science:
- Pharmacovigilance
- Health Informatics
- Observational Data Analysis
Background:
- Variations in data models and coding systems hinder systematic analysis of observational medical databases for safety surveillance.
- Existing clinical data models can be difficult for analysts to understand and may not support large-scale systematic analysis.
- A Common Data Model (CDM) can facilitate analysis and ensure faithful representation of source data.
Purpose of the Study:
- To validate the suitability of the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) for active safety surveillance.
- To assess the representation of diverse observational healthcare databases within the OMOP CDM.
- To evaluate the performance of analytic methods applied to data within the OMOP CDM.
Main Methods:
- Instantiated the OMOP CDM into a relational database.
- Loaded data from 10 different observational healthcare databases into separate instances.
- Developed and executed a comprehensive array of analytic methods on the instantiated OMOP CDM.
Main Results:
- The OMOP CDM acceptably represented data from 10 distinct observational databases using selected standardized terminologies.
- A range of analytic methods was developed and executed.
- The developed methods demonstrated sufficient performance for active safety surveillance.
Conclusions:
- The OMOP CDM, with standardized terminologies, provides acceptable data representation for active safety surveillance.
- The developed analytic methods are suitable for large-scale systematic analysis using the OMOP CDM.
- The OMOP CDM facilitates efficient and effective active safety surveillance across multiple databases.
Related Concept Videos
Data Validation
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
Nursing assessment guides are generally based on holistic models rather than medical...
Principles of Disease Surveillance
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...